Skip to main content
SpringerLink
Log in
Book cover

Alzheimer’s Turning Point pp 1–20Cite as

How Does Alzheimer’s Begin and Who Gets It?

  • Chapter
  • First Online:

  • 1237 Accesses

Abstract

Alzheimer’s disease, Alzheimer’s dementia or Alzheimer’s for short, is one of the grimmest diagnoses a physician can deliver to a patient. It conveys not only an unfaltering death sentence but an extended period of suffering, humiliation, and confusion before dying. In the USA, a person is diagnosed with this dementia every 67 s, and by 2050, it will be every 33 s. No one is sure what causes it, and as with any disease, knowing the cause of Alzheimer’s is the key to containing it. This book attempts to shine some light into the possible cause of Alzheimer’s and how this dementia can be prevented.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Alzheimer’s Association. 2014 Alzheimer’s disease facts and figures. Alzheimer’s Dement. 2014;10(2):16–20.

    Google Scholar 

  2. de la Torre JC, Mussivand T. Can disturbed brain microcirculation cause Alzheimer’ disease? Neurol Res. 1993;15:146–53.

    PubMed  Google Scholar 

  3. de la Torre JC. The vascular hypothesis of Alzheimer’s disease: bench to bedside and beyond. Neurodegener Dis. 2010;7(1–3):116–21.

    Article  PubMed  Google Scholar 

  4. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol. 1999;58:376–88.

    Article  CAS  PubMed  Google Scholar 

  5. Bryan KJ, Lee H, Perry G, Smith MA, Casadesus G. Transgenic mouse models of Alzheimer’s disease: behavioral testing and considerations. In: Buccafusco JJ, editor. Methods of behavior analysis in neuroscience. 2. Boca Raton (FL): CRC Press; 2009.

    Google Scholar 

  6. Robakis NK. Are Abeta and its derivatives causative agents or innocent bystanders in AD? Neurodeg Dis. 2010;7(1–3):32–7.

    Google Scholar 

  7. Lee HG, Castellani RJ, Zhu X, Perry G, Smith MA. Amyloid-beta in Alzheimer’s disease: the horse or the cart? Pathogenic or protective? Int J Exp Pathol. 2005;86(3):133–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Morris GP, Clark IA, Vissel B. Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer’s disease. Acta Neuropathol Commun. 2014;18(2):135.

    Google Scholar 

  9. Snitz BE, Weissfeld LA, Lopez OL, Kuller LH, Saxton J, Singhabahu DM, Klunk WE, Mathis CA, Price JC, Ives DG, Cohen AD, McDade E, Dekosky ST. Cognitive trajectories associated with beta-amyloid deposition in the oldest-old without dementia. Neurology. 2013;80:1378–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Rentz DM, Locascio JJ, Becker JA, Moran EK, Eng E, Buckner RL, Sperling RA, Johnson KA. Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol. 2010;67:353–64.

    PubMed  Google Scholar 

  11. Hedden T, Oh H, Younger AP, Patel TA. Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology. 2013;80:1341–1348. (plaques unrelated to AD).

    Google Scholar 

  12. Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A. Two-year follow-up of amyloid deposition in patients with Alzheimer’s disease. Brain. 2006;129:2856–66.

    Article  PubMed  Google Scholar 

  13. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–7.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Xekardaki A, Kövari E, Gold G, Papadimitropoulou A, Giacobini E, Herrmann F, Giannakopoulos P, Bouras C. Neuropathological changes in aging brain. Adv Exp Med Biol. 2015;821:11–7.

    Article  PubMed  Google Scholar 

  15. Weiss B. Alzheimer’s surgery: an intimate portrait. Bloomington, Indiana: AuthorHouse; 2005.

    Google Scholar 

  16. Alzheimer A. Uber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und phychish-gerichtliche Medizin, (Berlin) 1907;64:146–48.

    Google Scholar 

  17. Bick K, Amaducci L, Pepeu G, editors. Translation of the historic papers by Alois Alzheimer, Oskar Fischer, Francesco Bonfiglio, Emil Kraepelin, Gaetano Perusini. New York: Raven Press; 1987. The early story of Alzheimer’s disease.

    Google Scholar 

  18. Muller U, Winter P, Graeber M. A presenilin 1 mutation is the first case of Alzheimer’s disease. Lancet Neurol. 2013;12:128–9.

    Article  Google Scholar 

  19. Goedert M. Oskar Fischer and the study of dementia. Brain. 2009;32:1102–11.

    Google Scholar 

  20. de la Torre JC. Alzheimer’s disease: how does it start?J Alzheimers Dis. 2002;4(6):497–512.

    Google Scholar 

  21. de la Torre JC. Alzheimer’s disease is a vasocognopathy: a new term to describe its nature. Neurol Res. 2004;26(5):517–24.

    Article  PubMed  Google Scholar 

  22. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. Nun Study JAMA. 1997;277(10):813–7.

    CAS  PubMed  Google Scholar 

  23. Bowler JV, Eliasziw M, Steenhuis R, Munoz DG, Fry R, Merskey H, Hachinski VC. Comparative evolution of Alzheimer disease, vascular dementia, and mixed dementia. Arch Neurol. 1997;54(6):697–703.

    Article  CAS  PubMed  Google Scholar 

  24. Korczyn AD. Mixed dementia—the most common cause of dementia. Ann N Y Acad Sci. 2002;977:129–34.

    Article  PubMed  Google Scholar 

  25. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM. Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam Study. Ann Neurol. 2005;57:789–94.

    Article  PubMed  Google Scholar 

  26. Alsop DC, Dai W, Grossman M, Detre JA. Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer’s disease. J Alzheimers Dis. 2010;20(3):871–80.

    PubMed  PubMed Central  Google Scholar 

  27. de la Torre JC. Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004;3(3):184–90.

    Article  PubMed  Google Scholar 

  28. Leenders KL, Perani D, Lammertsma AA, Heather JD, Buckingham P, Healy MJR, Gibbs JM, Wise RJS, Hatazawa J, Herold S, Beaney RP, Brooks DJ, Spinks T, Rhodes C, Frackowiak RS, Jones T. Cerebral blood flow, blood volume and oxygen utilization. Brain. 1990;113:24–47.

    Article  Google Scholar 

  29. Viticchi G, Falsetti L, Buratti L, Boria C, Luzzi S, Bartolini M, Provinciali L, Silvestrini M. Framingham risk score can predict cognitive decline progression in Alzheimer’s disease. Neurobiol Aging. 2015;36(11):2940–5.

    Article  PubMed  Google Scholar 

  30. Kitaguchi H, Tomimoto H, Ihara M, Shibata M, Uemura K, Kalaria RN, Kihara T, Asada-Utsugi M, Kinoshita A, Takahashi R. Chronic cerebral hypoperfusion accelerates amyloid beta deposition in APPSwInd transgenic mice. Brain Res. 2009;19(1294):202–10.

    Article  Google Scholar 

  31. Rodrigue KM. Contribution of cerebral health to the diagnosis of Alzheimer’s disease. JAMA Neurol. 2013;70:438–9.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Liberski PP, Sikorska B, Hauw JJ, Kopp N. Ultrastructural characteristics (or evaluation) of Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies or prion diseases. Ultrastruct Pathol. 2010;34:351–61.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Texas at Austin, Austin, TX, USA

    Jack C. de la Torre

Authors
  1. Jack C. de la Torre
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jack C. de la Torre .

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

de la Torre, J.C. (2016). How Does Alzheimer’s Begin and Who Gets It?. In: Alzheimer’s Turning Point. Springer, Cham. https://doi.org/10.1007/978-3-319-34057-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-34057-9_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-34056-2

  • Online ISBN: 978-3-319-34057-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation